Glaive Medical Optics & AiRANACULUS

February 10, 2026

Beacon Angels members conducted the following new business at its meeting on Tuesday, February 10, 2026:

We entertained new funding proposals from the following companies:

  • Glaive Medical Optics, combining the most advanced digital processing and projection technologies to treat blindness using targeted digital vision.
  • AiRANACULUS, a deep tech startup advancing intelligent radio frequency (RF) and networking solutions with strong traction across defense and commercial sectors.

We heard updates from a Beacon Angels portfolio companies:

  • Joined Bio, creating a direct-to-patient marketplace to help researchers get biospecimens from patients, and ultimately enable patients to manage access to their data, participate in clinical trials, etc.
  • NIRA developing and selling infra-red laser wrinkle treatment devices.

We discussed updates on multiple funding rounds, by Series number:

  • Closed
    • S111C – AmplifiDx
    • S150 – Lenoss Medical
    • S151 – Jaia Robotics
  • Pending
    • S139D – Neosoma
    • S151 Akeyna

Members provided an update on companies in due diligence:

  • Viziverse AI, enabling ‘headsetless’ VR using Vision AI to deliver immersive, body-interactive “Reflective Reality” 3D experiences through everyday devices.

About Beacon Angels

Angel group, founded in 2006, that invests in early stage start-up companies--New England based only.
This entry was posted in Past Beacon Meetings and tagged , , , . Bookmark the permalink.